¼«ÀÖ½ûµØ

After practicing in a hospital pharmacy for many years, Rachel Slaton decided to join McWhorter School of Pharmacy in 2009. Slaton was charged with developing the skills labs and seminars for a course series in integrated pharmacy applications, and she successfully redesigned the drug literature evaluation course. In 2011, she was appointed to a tenure-track faculty position in drug information. In 2015, following closure of the ¼«ÀÖ½ûµØ Global Drug Information Service, she transitioned into ambulatory care. She has been practicing at the Brookwood-Baptist Health Primary Care since that time and is now board-certified as an ambulatory care specialist. Slaton is also a fellow of the Alabama Society of Health-system Pharmacist organization.

Degrees and Certifications

• Board Certification as an Ambulatory Care Specialist, Board of Pharmaceutical Specialties
• Pharmacy License, Alabama Board of Pharmacy
• Preceptor Certification, Alabama Board of Pharmacy
• Investigational Review Board (IRB) Member Training
• Immunization Certification Pharmacist Trainer, American Pharmacists Association

Awards and Honors

• Little T and Slaton RM. Morbidity and Mortality Benefits of Adding a Pharmacist to the Outpatient Collaborative Care Team in Primary Care: a Focus on Type II Diabetes Mellitus. Alabama Society of Health System Pharmacists Summer
• Clinical Meeting best poster award. June 2023
• Manis M, Cimino LH, Dugan BD, Brown SA, Kyle JA, Slaton R, Hughes PJ. Alabama Society of Health System Pharmacists Summer
• Clinical Meeting best poster award. June 2021
• Fellow ALSHP, September 2020
• ALSHP, Service Award September 2016
• ALSHP, Officer Award September 2016

Involvement

• Alabama Society of Health-Systems Pharmacist (ALSHP)
• Chair, Fellows Review Committee (2021)
• Fellows Review Committee (2021 – Present)
• Editorial Board, InPharmative Quarterly(2018 – Present))
• Practice Advancement Committee (2017 – 2020)
• Finance Committee(2016 – 2018)
• Secretary & Treasurer (Executive Committee (2014 – 2016)
• Chair, Finance Committee
• Co-Leader, Ambulatory Care Special Interest Group (SIG) (2015)
• Alabama Residency Conference Organizer (2000 – 2017)

Expertise

• Ambulatory care
• Drug information
• Medication safety
• Quality assurance and quality improvement
• Investigation review board
• Teaching/precepting

Research Areas

• Therapeutic use of drugs
• Medication safety and adverse events
• Patient adherence
• Pharmacist’s impact in primary care;
• Diabetes

Publications

• Slaton RM, Luthin D, Boyd JK. A pipe dream? Use of glucagon-like peptide receptor 1 (GLP-1) agonists for nicotine use disorder. Quart J Pharm & Pharmaceutics. 2021;01(01): 8–17.
• Smith A, DeHart RM, Cretton-Scott E, Slaton RM, Smith K. Prevalence of depression and anxiety among student pharmacists. Int J Med Pharm. 2020;8(2):1-8. DOI: 10.15640/ijmp.v8n2a1 URL: https://doi.org/10.15640/ijmp.v8n2a1
• Slaton RM, Boyd JK, Iranikhah MG. Romosozumb and sequential therapy in osteoporosis. Sr Care Pharm. 2020;3435(7):297-308. https://doi.org/10.4140/TCP.n.2020.297
• Motooka Y, Matsui T, Slaton RM, Umetsu R, Fukuda A, Naganuma M, Hasegawa S, Sasaoka S, Hatahira H, Iguchi K, Nakamura M. Adverse events of smoking cessation treatments (nicotine replacement therapy and non-nicotine prescription medication) and electronic cigarettes in the Food and Drug Administration Adverse Event Reporting System, 2004−2016. SAGE Open Med. 2018;6:1-11. doi: 10.1177/2050312118777953
• Kendrach MG, Freeman MK, Hughes PJ, Slaton RM. Drug Literature Evaluation I: Controlled Clinical Trial Evaluation. Drug Information A Guide for Pharmacists, 6^th Ed: Malone PM, Kier KL, Stanovich JE, Malone MJ. New York, NY:McGraw Hill Ed; 2017.
• Hughes PJ, Freeman MK, Slaton RM. Common issues in the medication use processes in nursing homes: a review of medication use improvement strategies. J Nurs Edu Pract. 2016;6(7): 81-90.
• Erwin BL, Slaton RM. Varenicline in the Treatment of Alcohol Use Disorders. Ann Pharmacother. 2014; 48(11) 1445–1455. DOI: 10.1177/1060028014545806. PMID: 25107421
• Slaton RM, Champion M, Palmore K. A Review of Paroxetine for the Treatment of Vasomotor Symptoms. J Pharm Pract. 2015 Jun;28(3):266-74. DOI: 10.1177/0897190014544785.
• Slaton RM, Thomas RH, Mbathi JW. Evidence for Therapeutic Uses of Nebulized Lidocaine in the Treatment of Intractable Cough and Asthma. Ann Pharmacother. 2013;47(4):578-85. 10.1345/aph.1R573
• Slaton RM, Cruthirds D. Indacaterol for Chronic Obstructive Pulmonary Disease. P&T Journal. 2012 Feb;37(2):86-98.
• Nelson, Monk-Tutor M, Slaton RM, Kendrach MG, Arnold JA. Student-Led Development, Delivery, and Assessment of an Integrated Learning Activity Focusing on Acute Myocardial Infarction. Curr Pharm Teach Learn. 2012 Jan;4(1):2-15. doi:10.1016/j.cptl.2011.10.002